Access the full text.
Sign up today, get DeepDyve free for 14 days.
Corey Tabit, Phetcharat Chen, Gene Kim, S. Fedson, G. Sayer, Mitchell Coplan, V. Jeevanandam, N. Uriel, J. Liao (2016)
Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical BleedingCirculation, 134
V. Karantalis, Darcy Difede, G. Gerstenblith, S. Pham, J. Symes, J. Zambrano, J. Fishman, P. Pattany, I. Mcniece, J. Conte, S. Schulman, Katherine Wu, Ashish Shah, Elayne Breton, J. Davis-Sproul, R. Schwarz, Gary Feigenbaum, Muzammil Mushtaq, V. Suncion, A. Lardo, I. Borrello, A. Mendizabal, Tomer Karas, J. Byrnes, M. Lowery, A. Heldman, J. Hare (2014)
Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac SurCirculation Research, 114
S. Arnold, J. Spertus, S. Vemulapalli, Zhuokai Li, Roland Matsouaka, S. Baron, A. Vora, M. Mack, M. Reynolds, J. Rumsfeld, D. Cohen (2017)
Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected Population: A Report From the STS/ACC Transcatheter Valve Therapy RegistryJAMA Cardiology, 2
J. Rogers, F. Pagani, A. Tatooles, G. Bhat, M. Slaughter, E. Birks, S. Boyce, S. Najjar, V. Jeevanandam, A. Anderson, I. Gregoric, H. Mallidi, Katrin Leadley, K. Aaronson, O. Frazier, C. Milano (2017)
Intrapericardial Left Ventricular Assist Device for Advanced Heart FailureThe New England Journal of Medicine, 376
O. Balcioglu, Hatice Kemal, S. Ertugay, P. Ozturk, Y. Engin, S. Nalbantgil, Ç. Engin, T. Yağdı, M. Ozbaran (2017)
Risk Factors of Gastrointestinal Bleeding After Continuous Flow Left Ventricular Assist DeviceASAIO Journal, 64
Rachna Kataria, U. Jorde (2018)
GI Bleeding During CF-LVAD Support: State of the Field.Cardiology in Review
Xiaohui Fang, A. Neyrinck, M. Matthay, J. Lee (2010)
Allogeneic Human Mesenchymal Stem Cells Restore Epithelial Protein Permeability in Cultured Human Alveolar Type II Cells by Secretion of Angiopoietin-1*♦The Journal of Biological Chemistry, 285
Corey Tabit, Mitchell Coplan, Phetcharat Chen, V. Jeevanandam, N. Uriel, J. Liao (2018)
Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 37 1
M. Mehra, D. Goldstein, N. Uriel, J. Cleveland, M. Yuzefpolskaya, C. Salerno, M. Walsh, C. Milano, C. Patel, G. Ewald, A. Itoh, D. Dean, A. Krishnamoorthy, W. Cotts, A. Tatooles, U. Jorde, B. Bruckner, J. Estep, V. Jeevanandam, G. Sayer, D. Horstmanshof, J. Long, Sanjeev Gulati, E. Skipper, J. O’Connell, G. Heatley, P. Sood, Y. Naka (2018)
Two‐Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart FailureThe New England Journal of Medicine, 378
V. Suncion, E. Ghersin, J. Fishman, J. Zambrano, V. Karantalis, Nicole Mandel, Katarina Nelson, G. Gerstenblith, Darcy Velazquez, Elayne Breton, K. Sitammagari, I. Schulman, Sabrina Taldone, Adam Williams, C. Sanina, Peter Johnston, J. Brinker, Peter Altman, Muzammil Mushtaq, B. Trachtenberg, A. Mendizabal, Melissa Tracy, Jose Silva, I. Mcniece, A. Lardo, R. George, J. Hare, A. Heldman (2014)
Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?: An Analysis From the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) Randomized TrialCirculation Research, 114
A. Heldman, Darcy Difede, J. Fishman, J. Zambrano, B. Trachtenberg, V. Karantalis, Muzammil Mushtaq, Adam Williams, V. Suncion, I. Mcniece, E. Ghersin, Victor Soto, Gustavo Lopera, Roberto Miki, H. Willens, R. Hendel, R. Mitrani, P. Pattany, Gary Feigenbaum, Behzad Oskouei, J. Byrnes, M. Lowery, Julio Sierra, Mariesty Pujol, Cindy Delgado, Phillip Gonzalez, Jose Rodriguez, Luiza Bagno, D. Rouy, Peter Altman, C. Foo, Jose Silva, Erica Anderson, R. Schwarz, A. Mendizabal, J. Hare (2014)
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.JAMA, 311 1
Rende Xu, Song Ding, Yi-chao Zhao, Jun Pu, B. He (2014)
Autologous transplantation of bone marrow/blood-derived cells for chronic ischemic heart disease: a systematic review and meta-analysis.The Canadian journal of cardiology, 30 11
A. Kanelidis, C. Premer, Juan Lopez, W. Balkan, J. Hare (2017)
Route of Delivery Modulates the Efficacy of Mesenchymal Stem Cell Therapy for Myocardial Infarction: A Meta-Analysis of Preclinical Studies and Clinical TrialsCirculation Research, 120
E. Perin, K. Borow, G. Silva, A. DeMaria, O. Marroquin, Paul Huang, J. Traverse, H. Krum, D. Skerrett, Yi Zheng, J. Willerson, S. Itescu, T. Henry (2015)
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure.Circulation research, 117 6
D. Ascheim, A. Gelijns, D. Goldstein, L. Moye, N. Smedira, Sangjin Lee, C. Klodell, Anita Szady, M. Parides, N. Jeffries, D. Skerrett, Doris Taylor, J. Rame, C. Milano, J. Rogers, J. Lynch, T. Dewey, Eric Eichhorn, B. Sun, D. Feldman, R. Simari, P. O'Gara, W. Taddei-Peters, Marissa Miller, Y. Naka, E. Bagiella, E. Rose, Y. Woo (2014)
Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist DevicesCirculation, 129
F. See, T. Seki, P. Psaltis, H. Sondermeijer, S. Gronthos, A. Zannettino, K. Govaert, M. Schuster, P. Kurlansky, D. Kelly, H. Krum, S. Itescu (2011)
Therapeutic effects of human STRO-3-selected mesenchymal precursor cells and their soluble factors in experimental myocardial ischemiaJournal of Cellular and Molecular Medicine, 15
E. Birks, Robert George, M. Hedger, T. Bahrami, P. Wilton, C. Bowles, C. Webb, R. Bougard, M. Amrani, M. Yacoub, G. Dreyfus, A. Khaghani (2011)
Reversal of Severe Heart Failure With a Continuous-Flow Left Ventricular Assist Device and Pharmacological Therapy: A Prospective StudyCirculation, 123
This phase 2 clinical trial investigates whether injecting the myocardium of patients with heart failure with a high dose of mesenchymal precursor cells derived from bone marrow stem cells, compared with a sham injection, repairs myocardial damage enough to facilitate weaning from left ventricular assist devices (LVADs).
JAMA – American Medical Association
Published: Mar 26, 2019
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.